Xydalba Utilization Registry in Germany
Xydalba Utilization Registry: A Multicenter, Prospective and Retrospective Registry to Characterize the Use of Xydalba
Sponsor: AMS Advanced Medical Services GmbH
Terminated
Terminated
Other terminated trials from AMS Advanced Medical Services GmbH
More terminations from AMS Advanced Medical Services GmbH
Other Bacterial Infections trials with similar outcome
A observational or N/A phase clinical study on Bacterial Infections, this trial is terminated or withdrawn. The trial is conducted by AMS Advanced Medical Services GmbH and has accumulated 9 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2022 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Apr 2022 [monthly]
Terminated
▶ Show 4 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jan 2020 — Aug 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Dec 2019 — Jan 2020 [monthly]
Not Yet Recruiting
-
Nov 2018 — Dec 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- AMS Advanced Medical Services GmbH
- Correvio International Sarl
- PrimeVigilance
For direct contact, visit the study record on ClinicalTrials.gov .